Global Japanese Encephalitis Virus Vaccine Market Insights and Forecast to 2028
Summary:
Market Analysis and Insights: Global Japanese Encephalitis Virus Vaccine Market
Japanese Encephalitis vaccine info for parents, public, and healthcare professionals.
Due to the COVID-19 pandemic, the global Japanese Encephalitis Virus Vaccine market size is estimated to be worth US$ 220.9 million in 2022 and is forecast to a readjusted size of US$ 300.3 million by 2028 with a CAGR of 5.3% during the review period. Fully considering the economic change by this health crisis, Inactivated Vaccine accounting for % of the Japanese Encephalitis Virus Vaccine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Public segment is altered to an % CAGR throughout this forecast period.
China Japanese Encephalitis Virus Vaccine market size is valued at US$ million in 2021, while the US and Europe Japanese Encephalitis Virus Vaccine are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Japanese Encephalitis Virus Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Japanese Encephalitis Virus Vaccine include Research Foundation for Microbial Diseases of Osaka University, Valneva Austria GmbH, Chengdu Institute, Liaoning Dacheng and Wuhan Institute, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Market Segments
The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.
Segment by Type
Inactivated Vaccine
Live Attenuated Vaccine
Segment by Application
Public
Private
Consequence of Covid-19 Pandemic
The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Japanese Encephalitis Virus Vaccine market back to the pre-covid levels.
Trends & Prospects
In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.
By Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Outlook
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Research Foundation for Microbial Diseases of Osaka University
Valneva Austria GmbH
Chengdu Institute
Liaoning Dacheng
Wuhan Institute
Frequently Asked Questions
Which is the most lucrative product segment in the Japanese Encephalitis Virus Vaccine market?
Which are the prominent strategies of the Japanese Encephalitis Virus Vaccine market players?
Which factors are increasing the competition in the Japanese Encephalitis Virus Vaccine market?
Which are the recommendations provided by the Japanese Encephalitis Virus Vaccine industry experts?
Which region will witness rewarding growth during the forecast period?
What factors will curb the Japanese Encephalitis Virus Vaccine market growth?
Which product segment will register the fastest growth rate in the Japanese Encephalitis Virus Vaccine market?
Which emerging trends will impact the Japanese Encephalitis Virus Vaccine market growth?
Which are the high-impact rendering factors in the Japanese Encephalitis Virus Vaccine market?
Which companies will maintain their lead on the Japanese Encephalitis Virus Vaccine market?
Table of Contents
1 Study Coverage
1.1 Japanese Encephalitis Virus Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Japanese Encephalitis Virus Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Market by Application
1.3.1 Global Japanese Encephalitis Virus Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Public
1.3.3 Private
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Japanese Encephalitis Virus Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Japanese Encephalitis Virus Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Japanese Encephalitis Virus Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Japanese Encephalitis Virus Vaccine Sales by Region
2.4.1 Global Japanese Encephalitis Virus Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Japanese Encephalitis Virus Vaccine by Region (2023-2028)
2.5 Global Japanese Encephalitis Virus Vaccine Revenue by Region
2.5.1 Global Japanese Encephalitis Virus Vaccine Revenue by Region (2017-2022)
2.5.2 Global Japanese Encephalitis Virus Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Japanese Encephalitis Virus Vaccine Sales by Manufacturers
3.1.1 Global Top Japanese Encephalitis Virus Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Japanese Encephalitis Virus Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Japanese Encephalitis Virus Vaccine in 2021
3.2 Global Japanese Encephalitis Virus Vaccine Revenue by Manufacturers
3.2.1 Global Japanese Encephalitis Virus Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Japanese Encephalitis Virus Vaccine Revenue in 2021
3.3 Global Japanese Encephalitis Virus Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Japanese Encephalitis Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Japanese Encephalitis Virus Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Japanese Encephalitis Virus Vaccine Sales by Type
4.1.1 Global Japanese Encephalitis Virus Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Japanese Encephalitis Virus Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Japanese Encephalitis Virus Vaccine Revenue by Type
4.2.1 Global Japanese Encephalitis Virus Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Japanese Encephalitis Virus Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Japanese Encephalitis Virus Vaccine Price by Type
4.3.1 Global Japanese Encephalitis Virus Vaccine Price by Type (2017-2022)
4.3.2 Global Japanese Encephalitis Virus Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Japanese Encephalitis Virus Vaccine Sales by Application
5.1.1 Global Japanese Encephalitis Virus Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Japanese Encephalitis Virus Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Japanese Encephalitis Virus Vaccine Revenue by Application
5.2.1 Global Japanese Encephalitis Virus Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Japanese Encephalitis Virus Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Japanese Encephalitis Virus Vaccine Price by Application
5.3.1 Global Japanese Encephalitis Virus Vaccine Price by Application (2017-2022)
5.3.2 Global Japanese Encephalitis Virus Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Japanese Encephalitis Virus Vaccine Market Size by Type
6.1.1 North America Japanese Encephalitis Virus Vaccine Sales by Type (2017-2028)
6.1.2 North America Japanese Encephalitis Virus Vaccine Revenue by Type (2017-2028)
6.2 North America Japanese Encephalitis Virus Vaccine Market Size by Application
6.2.1 North America Japanese Encephalitis Virus Vaccine Sales by Application (2017-2028)
6.2.2 North America Japanese Encephalitis Virus Vaccine Revenue by Application (2017-2028)
6.3 North America Japanese Encephalitis Virus Vaccine Market Size by Country
6.3.1 North America Japanese Encephalitis Virus Vaccine Sales by Country (2017-2028)
6.3.2 North America Japanese Encephalitis Virus Vaccine Revenue by Country (2017-2028)
6.3.3 the United States
6.3.4 Canada
7 Europe
7.1 Europe Japanese Encephalitis Virus Vaccine Market Size by Type
7.1.1 Europe Japanese Encephalitis Virus Vaccine Sales by Type (2017-2028)
7.1.2 Europe Japanese Encephalitis Virus Vaccine Revenue by Type (2017-2028)
7.2 Europe Japanese Encephalitis Virus Vaccine Market Size by Application
7.2.1 Europe Japanese Encephalitis Virus Vaccine Sales by Application (2017-2028)
7.2.2 Europe Japanese Encephalitis Virus Vaccine Revenue by Application (2017-2028)
7.3 Europe Japanese Encephalitis Virus Vaccine Market Size by Country
7.3.1 Europe Japanese Encephalitis Virus Vaccine Sales by Country (2017-2028)
7.3.2 Europe Japanese Encephalitis Virus Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 UK
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Japanese Encephalitis Virus Vaccine Market Size by Type
8.1.1 Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Japanese Encephalitis Virus Vaccine Market Size by Application
8.2.1 Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Japanese Encephalitis Virus Vaccine Market Size by Region
8.3.1 Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Japanese Encephalitis Virus Vaccine Market Size by Type
9.1.1 Latin America Japanese Encephalitis Virus Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Japanese Encephalitis Virus Vaccine Revenue by Type (2017-2028)
9.2 Latin America Japanese Encephalitis Virus Vaccine Market Size by Application
9.2.1 Latin America Japanese Encephalitis Virus Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Japanese Encephalitis Virus Vaccine Revenue by Application (2017-2028)
9.3 Latin America Japanese Encephalitis Virus Vaccine Market Size by Country
9.3.1 Latin America Japanese Encephalitis Virus Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Japanese Encephalitis Virus Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Japanese Encephalitis Virus Vaccine Market Size by Type
10.1.1 Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Japanese Encephalitis Virus Vaccine Market Size by Application
10.2.1 Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Japanese Encephalitis Virus Vaccine Market Size by Country
10.3.1 Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Research Foundation for Microbial Diseases of Osaka University
11.1.1 Research Foundation for Microbial Diseases of Osaka University Corporation Information
11.1.2 Research Foundation for Microbial Diseases of Osaka University Overview
11.1.3 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Research Foundation for Microbial Diseases of Osaka University Recent Developments
11.2 Valneva Austria GmbH
11.2.1 Valneva Austria GmbH Corporation Information
11.2.2 Valneva Austria GmbH Overview
11.2.3 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Valneva Austria GmbH Recent Developments
11.3 Chengdu Institute
11.3.1 Chengdu Institute Corporation Information
11.3.2 Chengdu Institute Overview
11.3.3 Chengdu Institute Japanese Encephalitis Virus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Chengdu Institute Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Chengdu Institute Recent Developments
11.4 Liaoning Dacheng
11.4.1 Liaoning Dacheng Corporation Information
11.4.2 Liaoning Dacheng Overview
11.4.3 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Liaoning Dacheng Recent Developments
11.5 Wuhan Institute
11.5.1 Wuhan Institute Corporation Information
11.5.2 Wuhan Institute Overview
11.5.3 Wuhan Institute Japanese Encephalitis Virus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Wuhan Institute Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Wuhan Institute Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Japanese Encephalitis Virus Vaccine Industry Chain Analysis
12.2 Japanese Encephalitis Virus Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Japanese Encephalitis Virus Vaccine Production Mode & Process
12.4 Japanese Encephalitis Virus Vaccine Sales and Marketing
12.4.1 Japanese Encephalitis Virus Vaccine Sales Channels
12.4.2 Japanese Encephalitis Virus Vaccine Distributors
12.5 Japanese Encephalitis Virus Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Japanese Encephalitis Virus Vaccine Industry Trends
13.2 Japanese Encephalitis Virus Vaccine Market Drivers
13.3 Japanese Encephalitis Virus Vaccine Market Challenges
13.4 Japanese Encephalitis Virus Vaccine Market Restraints
14 Key Findings in The Global Japanese Encephalitis Virus Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets